Skip to main content
. 2019 Dec 19;19(Suppl 6):271. doi: 10.1186/s12911-019-0964-z

Table 1.

Top DE-miRNAs from Case vs. control (18 DE-miRs total) and Treatment vs. case (8 DE-miRs total)

Case vs. control Treatment vs. case
miRNA log2 FC Relevance to Neuropsychiatric disease Ref miRNA log2FC Relevance to Neuropsychiatric disease Ref
miR-1298 1.70 NA miR-7a-5p −1.10 NA
miR-139-5p 1.28 May Marks sensitivity to stress [22] miR-181a-2-3p 1.05 Related to Cerebral cavernous malformations [23]
miR-139-3p 1.41 ↓by Nerve Growth Factor treatment [24] miR-200a-3p 1.02 Mediate antidepressant-like effects in stressed rat [25]
miR-34c-5p 1.23 ↓in blood&brain of MDD patients [26, 27] miR-214-3p −2.05 adjusts Depressive-like Behaviors [28]
miR-448-3p 1.61 NA miR-32-3p −1.24 NA
miR-204-5p 1.07 Suppressed by morphine [29] miR-6215 4.16 NA
miR-10b-5p −1.29 Related to Parkinson disease [30] miR-653-5p − 1.02 NA
miR-214-3p 2.02 adjusts Depressive-like Behaviors [31] miR-10b-5p 1.36 Related to Parkinson disease [30]